PM20D2
Xaa-Arg dipeptidase
Also known as: ACY1L2, bA63L7.3, P20D2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IYS1
- Gene
- PM20D2
- Ensembl
- ENSG00000146281
- Chromosome
- 6
- Canonical length
- 436 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Enables dipeptidase activity and identical protein binding activity. Acts upstream of or within proteolysis and regulation of protein metabolic process. Located in nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
436 residues, UniProt reviewed canonical sequence.
>Q8IYS1|PM20D2
1 MRPGGERPVE GGACNGRSEL ELLKLRSAEC IDEAAERLGA LSRAIWSQPE LAYEEHHAHR
61 VLTHFFEREP PAASWAVQPH YQLPTAFRAE WEPPEARAPS ATPRPLHLGF LCEYDALPGI
121 GHACGHNLIA EVGAAAALGV RGALEGLPRP PPPVKVVVLG TPAEEDGGGK IDLIEAGAFT
181 NLDVVFMAHP SQENAAYLPD MAEHDVTVKY YGKASHSASY PWEGLNALDA AVLAYNNLSV
241 FRQQMKPTWR VHGIIKNGGV KPNIIPSYSE LIYYFRAPSM KELQVLTKKA EDCFRAAALA
301 SGCTVEIKGG AHDYYNVLPN KSLWKAYMEN GRKLGIEFIS EDTMLNGPSG STDFGNVSFV
361 VPGIHPYFHI GSNALNHTEQ YTEAAGSQEA QFYTLRTAKA LAMTALDVIF KPELLEGIRE
421 DFKLKLQEEQ FVNAVELocalizationUniProt · AlphaFold · HPA
Whether an antibody against PM20D2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 28 nTPM
- prostate: 24 nTPM
- tongue: 15 nTPM
- blood vessel: 15 nTPM
- ovary: 14 nTPM
- retina: 13 nTPM
Single-cell type
- thymic myoid cells: 241 nCPM
- myonuclei: 203 nCPM
- prostatic glandular cells: 83 nCPM
- cardiomyocytes: 61 nCPM
- smooth muscle cells: 59 nCPM
- cone photoreceptor cells: 54 nCPM
Immune cell
- NK-cell: 1.9 nTPM
- memory B-cell: 1.5 nTPM
- naive CD4 T-cell: 1.4 nTPM
- memory CD8 T-cell: 1.3 nTPM
- eosinophil: 1.2 nTPM
- MAIT T-cell: 1.2 nTPM
Brain region
- choroid plexus: 23 nTPM
- cerebellum: 17 nTPM
- hypothalamus: 15 nTPM
- basal ganglia: 12 nTPM
- medulla oblongata: 12 nTPM
- amygdala: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.99
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.98
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Peptidase M20
- Peptidase M20, dimerisation domain
- Bacterial exopeptidase dimerisation domain
- Peptidase family M20/M25/M40
- Peptidase dimerisation domain
- Xaa-Arg dipeptidase
- Peptidase M20/M20A family hydrolases
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PM20D2 as an antibody target. Whether an autoantibody or antibody against PM20D2 could matter depends on whether native PM20D2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PM20D2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PM20D2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...